C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/44 (2006.01) A61K 31/505 (2006.01) C07D 487/04 (2006.01)
Patent
CA 2303280
Corticotropin releasing factor (CRF) antagonists of formula (I) and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as well as treatment of immunological, cardiovascular or heart- related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress in mammals.
L'invention porte sur des antagonistes du facteur de libération de la cortitropine (CRF), de formule (I) et leur emploi dans le traitement chez les mammifères: de troubles psychiatriques, de maladies neurologiques, de troubles liés à l'anxiété, de troubles dus au stress post-traumatique, de la paralysie supranucléaire, des troubles de la nutrition, des maladies immunologiques, cardio-vasculaires, ou cardiaques, et de l'hypersensibilité du colon liée à des dérangements psychopathologiques et au stress.
Arvanitis Argyrios G.
Bakthavatchalam Rajagopal
Beck James P.
Gilligan Paul J.
Bristol-Myers Squibb Pharma Company
Dimock Stratton Llp
Dupont Pharmaceuticals Company
LandOfFree
Heterocyclyl-substituted ring-fused pyridines and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclyl-substituted ring-fused pyridines and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclyl-substituted ring-fused pyridines and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2080760